Compare ARQT & PPLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARQT | PPLI |
|---|---|---|
| Founded | 2016 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 2.7B |
| IPO Year | 2020 | 2020 |
| Metric | ARQT | PPLI |
|---|---|---|
| Price | $27.14 | $43.28 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 11 |
| Target Price | $40.38 | ★ $50.80 |
| AVG Volume (30 Days) | ★ 2.4M | 1.1M |
| Earning Date | 11-04-2026 | 11-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 88.79 | 79.97 |
| EPS | ★ 0.09 | N/A |
| Revenue | $376,072,000.00 | ★ $4,365,235,000.00 |
| Revenue This Year | $44.19 | N/A |
| Revenue Next Year | $29.31 | $0.11 |
| P/E Ratio | $314.67 | ★ N/A |
| Revenue Growth | ★ 91.34 | N/A |
| 52 Week Low | $19.30 | $34.79 |
| 52 Week High | $34.80 | $48.32 |
| Indicator | ARQT | PPLI |
|---|---|---|
| Relative Strength Index (RSI) | 44.15 | 61.22 |
| Support Level | $25.08 | $40.37 |
| Resistance Level | $28.54 | $47.96 |
| Average True Range (ATR) | 1.58 | 1.71 |
| MACD | -0.48 | 0.54 |
| Stochastic Oscillator | 19.64 | 86.85 |
Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.
People Inc is a media and publishing business that operates a portfolio of brands, including PEOPLE, Food & Wine, Travel + Leisure, InStyle, Better Homes & Gardens, and Southern Living. The company also holds a minority equity stake in MGM Resorts International.